Global /Japan /Healthcare /Medical Distribution /9987
chevron_leftBack

Suzuken Co., Ltd.

9987
TSE: 9987 Delayed
5,179JPY 5.7%
36.19 USD
As of 24 April 2025, Suzuken Co., Ltd. has a market cap of $2.41B USD, ranking #4736 globally and #369 in Japan. It ranks #423 in the Healthcare sector, and #16 in the Medical Distribution industry.
Global Rank
4736
Country Rank
369
Sector Rank
423
Industry Rank
16
Key Stats
Market Cap
$2.41BUSD
344.3B JPY
Enterprise Value
$970.58MUSD
138.9B JPY
Revenue (TTM)
$16.85BUSD
2.41T JPY
EBITDA (TTM)
$326.04MUSD
46.66B JPY
Net Income (TTM)
$238.91MUSD
34.19B JPY
EBITDA Margin
1.9%
Profit Margin
1.4%
PE Ratio
11.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Shigeru Asano open_in_new
Employees
13,086
Founded
1932
Website
suzuken.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
5.7% 6.7% 2.2% 9.6% 0.6% 14%
Upcoming Earnings
Earnings Date
Tue, May 13

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
9987
株式会社スズケン
ISIN: JP3398000004
Shares Out.:
67.523M1 Shares Float: 52.37M2
TV:
SA:
YF:
GF:
BA:
MS:
5.18K JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Suzuken Co., Ltd.

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals, and diagnostic reagents focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment is involved in the medication instruction and drug management for in-home patients, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment delivers drugs; provides nursing care services; manufactures, sells, and leases nursing care and medical equipment, such as electrocardiographs, blood pressure monitors, and stethoscopes under Kenz brand name; distributes orphan drugs; develops and operates a product control system for medical materials; sells food products and fixtures and fittings; and develops, manages, and maintains healthcare platforms. This segment also engages in publication and PR activities in the field of medical care and health; and insurance agency business, as well as provides remote image diagnostic support services. In addition, it engages in pharmaceutical logistics business. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

Similar Companies

Industry: Medical Distribution (Japan)
Name
Market Cap diff.
MediPal Holdings Corp.
7459
$3.53B
505.84B JPY
47%
Alfresa Holdings Corp.
2784
$2.79B
399.21B JPY
16%
Toho Holdings Co., Ltd.
8129
$2.01B
287.37B JPY
-17%
AS ONE Corp.
7476
$1.16B
165.78B JPY
-52%
Vital KSK Holdings, Inc.
3151
$458.42M
65.61B JPY
-81%
Industry: Medical Distribution (Global)
Name
Market Cap diff.
McKesson Corp.
MCK
$86.84B
4K%
Cencora, Inc.
COR
$55.21B
2K%
Cardinal Health, Inc.
CAH
$32.47B
1K%
SIGMA HEALTHCARE Ltd.
SIG
$21.56B
33.88B AUD
796%
Shanghai Pharmaceuticals Holding Co., Ltd.
601607
$8.27B
60.23B CNY
244%